跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
KIRSTY - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
KIRSTY
Authorized
STANDARD
KIRSTY
biocon sdn.bhd
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
fa609f610f4fa9a4
Company
biocon sdn.bhd
Type
Standard
Approval Details
Approval Id
fa609f610f4fa9a4
Drug Approval Canada Name
KIRSTY
Product Name
KIRSTY
Status
Marketed
Status Date
2024-04-04
Original Market Date
2022-10-20
Din
02520974
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
Schedule D
Ahfs
68:20.08
Atc Original
A10AB05 INSULIN ASPART
Atc Name
a 10 ab 05
Aig Number
0144802001
Company Name
biocon sdn.bhd
Company Address
No. 1, Jalan Bioteknologi 1, Kawasan Perindustrian Silc, Iskandar Puteri, Johor, Malaysia, 79200
Active Ingredients
INSULIN ASPART
100 UNIT / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
fa609f610f4fa9a4
Type
Standard
Back to Health Canada Approvals